Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT)

被引：0
|
作者：
Lorch, A.
Rick, O.
Hartmann, J. T.
Metzner, B.
Glasmacher, A.
Berdel, W.
Schirren, R.
Bokemeyer, C.
Beyer, J.
机构：
[1] Univ Klinikum Giessen & Marburg, Marburg, Germany
[2] Klin Reinhardshohe, Bad Wildungen, Germany
[3] Univ Klinikum Tuebingen, Tubingen, Germany
[4] Klinikum Oldenburg, Oldenburg, Germany
[5] Univ Klinikum Bonn, Bonn, Germany
[6] Univ Klinikum Muenster, Munster, Germany
[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany
[8] Urban Krankenhaus Berlin, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5086
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)
    Taza, Fadi
    Abonour, Rafat
    Zaid, Mohammad Abu
    Althouse, Sandra K.
    Anouti, Bilal
    Akel, Reem
    Hanna, Nasser H.
    Adra, Nabil
    Einhorn, Lawrence H.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 213 - 220
  • [22] Salvage high-dose chemotherapy for germ cell tumors
    Feldman, Darren R.
    Powles, Thomas
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (08) : 355 - 362
  • [23] High-dose chemotherapy in germ-cell tumors
    Droz, JP
    Culine, S
    Biron, P
    Kramar, A
    ANNALS OF ONCOLOGY, 1996, 7 (10) : 997 - 1003
  • [24] Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
    Taza, Fadi
    Abonour, Rafat
    Althouse, Sandra K.
    Ashkar, Ryan
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Kessler, Kenneth A.
    Adra, Nabil
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] FDG-PET for the evaluation of high-dose chemotherapy (HD-CTX) in patients with metastatic germ cell tumors (GCT)
    Bokemeyer, G
    Kollmannsberger, O
    Sokler, W
    Dohmen, BM
    Oechsle, K
    Hartmann, JT
    Pfannenberg, AC
    Bares, R
    Kanz, L
    ANNALS OF ONCOLOGY, 1998, 9 : 56 - 56
  • [26] Patterns of relapse after primary or salvage high-dose chemotherapy in patients with advanced nonseminomatous germ cell tumors
    Oechsle, K.
    Lorch, A.
    Honecker, F. U.
    Kollmannsberger, C.
    Hartmann, J. T.
    Boehlke, I.
    Beyer, J.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor
    Connell, Brendan J.
    Patel, Manisha J.
    Tretter, Christopher G.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (04) : E441 - E443
  • [28] High-dose chemotherapy (HDCT) plus peripheral-blood stem-cell transplant (PBSCT) for patients (pts) with relapsed germ-cell tumors (GCT) and active brain metastases (mets).
    Kalra, Maitri
    Adra, Nabil
    Mckay, John
    Abonour, Rafat
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] High-dose chemotherapy (HDCT) for recurrent ovarian germ cell tumors (OGCT): Indiana University (IU) experience.
    Ammakkanavar, Natraj Reddy
    Matei, Daniela
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
    Darren R Feldman
    Robert J Motzer
    Dean F Bajorin
    Nature Clinical Practice Urology, 2008, 5 : 78 - 79
12345